Rocio D. Marchese

2.3k total citations
21 papers, 1.2k citations indexed

About

Rocio D. Marchese is a scholar working on Epidemiology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rocio D. Marchese has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 6 papers in Immunology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rocio D. Marchese's work include Pneumonia and Respiratory Infections (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Respiratory viral infections research (6 papers). Rocio D. Marchese is often cited by papers focused on Pneumonia and Respiratory Infections (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers) and Respiratory viral infections research (6 papers). Rocio D. Marchese collaborates with scholars based in United States, Israel and Slovakia. Rocio D. Marchese's co-authors include Richard McFetridge, Michael J. Caulfield, Narendra Chirmule, Susan B. Manoff, Michael N. Oxman, Adriana Weinberg, Myron J. Levin, Gary R. Johnson, Michael R. Irwin and Fubao Wang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Rocio D. Marchese

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rocio D. Marchese United States	15	904	219	164	105	104	21	1.2k
R. Berger Switzerland	20	748 0.8×	161 0.7×	73 0.4×	213 2.0×	160 1.5×	44	1.1k
Marie Studahl Sweden	22	780 0.9×	135 0.6×	130 0.8×	364 3.5×	198 1.9×	55	1.3k
Adriana Weinberg United States	24	1.3k 1.4×	370 1.7×	62 0.4×	336 3.2×	226 2.2×	38	2.0k
Dereck Tait South Africa	13	620 0.7×	179 0.8×	90 0.5×	389 3.7×	54 0.5×	23	1.0k
John D. Kriesel United States	20	551 0.6×	217 1.0×	55 0.3×	211 2.0×	46 0.4×	37	949
Kimmo Linnavuori Finland	16	805 0.9×	147 0.7×	167 1.0×	338 3.2×	47 0.5×	26	1.1k
Antonio Boschini Italy	23	717 0.8×	193 0.9×	64 0.4×	470 4.5×	85 0.8×	40	1.5k
Judy Zeh United States	7	925 1.0×	84 0.4×	131 0.8×	333 3.2×	90 0.9×	11	1.1k
Jiřı́ Beran Czechia	23	832 0.9×	334 1.5×	61 0.4×	515 4.9×	265 2.5×	82	1.5k
A. J. Nahmias United States	16	1.1k 1.2×	183 0.8×	74 0.5×	183 1.7×	113 1.1×	31	1.3k

Countries citing papers authored by Rocio D. Marchese

Since Specialization

Citations

This map shows the geographic impact of Rocio D. Marchese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocio D. Marchese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocio D. Marchese more than expected).

Fields of papers citing papers by Rocio D. Marchese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocio D. Marchese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocio D. Marchese. The network helps show where Rocio D. Marchese may publish in the future.

Co-authorship network of co-authors of Rocio D. Marchese

This figure shows the co-authorship network connecting the top 25 collaborators of Rocio D. Marchese. A scholar is included among the top collaborators of Rocio D. Marchese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocio D. Marchese. Rocio D. Marchese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andrews, Charles P., Steven Folkerth, Richard Rupp, et al.. (2018). Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age. Vaccine. 36(45). 6875–6882. 33 indexed citations

Greenberg, David, Timo Vesikari, David Hurley, et al.. (2018). Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Vaccine. 36(45). 6883–6891. 78 indexed citations

Ciprero, Karen L., Rocio D. Marchese, Patrick O. Richard, et al.. (2016). Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes. Human Vaccines & Immunotherapeutics. 12(8). 2135–2141. 3 indexed citations

McFetridge, Richard, Ajoke Sobanjo-ter Meulen, Steven Folkerth, et al.. (2015). Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults. Vaccine. 33(24). 2793–2799. 49 indexed citations

Meulen, Ajoke Sobanjo-ter, Timo Vesikari, Michael J. Dallas, et al.. (2014). Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 34(2). 186–194. 47 indexed citations

Irwin, Michael R., Myron J. Levin, Mark L. Laudenslager, et al.. (2013). Varicella Zoster Virus-Specific Immune Responses to a Herpes Zoster Vaccine in Elderly Recipients With Major Depression and the Impact of Antidepressant Medications. Clinical Infectious Diseases. 56(8). 1085–1093. 63 indexed citations

Irwin, Michael R., Myron J. Levin, Carmen Carrillo, et al.. (2011). Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behavior and Immunity. 25(4). 759–766. 62 indexed citations

Goldblatt, David, Lindsey Ashton, Yuhua Zhang, Joseph M. Antonello, & Rocio D. Marchese. (2011). Comparison of a New Multiplex Binding Assay versus the Enzyme-Linked Immunosorbent Assay for Measurement of Serotype-Specific Pneumococcal Capsular Polysaccharide IgG. Clinical and Vaccine Immunology. 18(10). 1744–1751. 23 indexed citations

Musher, Daniel M., Susan B. Manoff, Richard McFetridge, et al.. (2011). Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Human Vaccines. 7(9). 919–928. 65 indexed citations

10.

Musher, Daniel M., Susan B. Manoff, Richard McFetridge, et al.. (2010). Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle‐Aged and Older Adults. The Journal of Infectious Diseases. 201(4). 516–524. 126 indexed citations

11.

Manoff, Susan B., et al.. (2010). Antibody persistence 10 years after 1st and 2nd doses of 23-valent pneumococcal polysaccharide vaccine (PN23), and immunogenicity and safety of 2nd and 3rd doses in older adults. International Journal of Infectious Diseases. 14. e454–e454. 3 indexed citations

12.

Manoff, Susan B., Charles Liss, Michael J. Caulfield, et al.. (2010). Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years. The Journal of Infectious Diseases. 201(4). 525–533. 58 indexed citations

13.

Marchese, Rocio D., Joseph M. Antonello, Tina Green, et al.. (2009). Optimization and Validation of a Multiplex, Electrochemiluminescence-Based Detection Assay for the Quantitation of Immunoglobulin G Serotype-Specific Antipneumococcal Antibodies in Human Serum. Clinical and Vaccine Immunology. 16(3). 387–396. 69 indexed citations

14.

Levin, Myron J., Michael N. Oxman, Gary R. Johnson, et al.. (2008). Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine. The Journal of Infectious Diseases. 197(6). 825–835. 273 indexed citations

15.

Rubinstein, Leonard J., et al.. (2008). Complexities of Clinical Assay Development and Optimization Prior to First-in-Man Immunization Trials – A Description of Immunogenicity Assay Development for the Testing of Samples from a Phase 1 Alzheimer's Vaccine Trial. Journal of Immunoassay and Immunochemistry. 29(4). 332–347. 9 indexed citations

16.

Barton, Michelle, Samia Wasfy, Diane Hébert, et al.. (2008). Sustainability of humoral responses to varicella vaccine in pediatric transplant recipients following a pretransplantation immunization strategy. Pediatric Transplantation. 13(8). 1007–1013. 8 indexed citations

17.

Wang, Yue, et al.. (2006). The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection. Journal of Medical Virology. 78(12). 1679–1687. 42 indexed citations

18.

Marchese, Rocio D., et al.. (2006). Enzyme-Linked Immunosorbent Assay for Measuring Antibodies to Pneumococcal Polysaccharides for the PNEUMOVAX 23 Vaccine: Assay Operating Characteristics and Correlation to the WHO International Assay. Clinical and Vaccine Immunology. 13(8). 905–912. 24 indexed citations

19.

Ault, Kevin A., et al.. (2005). Minimum serum antibody levels associated with protection from human papillomavirus 16 (HPV 16) reinfection among placebo subjects. Journal of Clinical Oncology. 23(16_suppl). 5024–5024. 1 indexed citations

20.

Esser, Mark T., Rocio D. Marchese, Lisa Kierstead, et al.. (2003). Memory T cells and vaccines. Vaccine. 21(5-6). 419–430. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact